Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Validation of the IPF-specific version of St. George's Respiratory Questionnaire

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Risk factors for diagnostic delay in idiopathic pulmonary fibrosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prevalence and course of disease after lung resection in primary ciliary dyskinesia: a cohort & nested case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Electronic applications for the CFQ-R scoring

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Silent Hypoxia in Patients with SARS CoV-2 Infection before Hospital Discharge

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Increased respiratory morbidity in individuals with interstitial lung abnormalities

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Treatment with methotrexate and risk of lung disease in patients with rheumatoid arthritis: a nationwide population-based cohort study from Denmark

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  4. Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Patients with idiopathic pulmonary fibrosis (IPF) have impaired health-related quality of life (HRQL). To measure HRQL, an IPF-specific version of the St. George's Respiratory Questionnaire (SGRQ-I) was developed, but not sufficiently validated. This study aimed to assess the validity (i.a. known-groups validity and concurrent validity) and test-retest reliability of SGRQ-I in IPF patients with different disease durations.

METHODS: Patients with IPF were consecutively recruited and completed SGRQ, SGRQ-I, King's Brief Interstitial Lung Disease questionnaire (K-BILD), University of California, San Diego Shortness of Breath Questionnaire (SOBQ) and Short Form-36 (SF-36) along with pulmonary function tests and a 6-min walk test (6MWT) at baseline. After two weeks, SGRQ-I and Global Rating of Change Scales (GRCS) were completed.

RESULTS: At baseline and after two weeks, 150 and 134 patients completed the questionnaires, respectively. The internal consistency of SGRQ-I was high (Cronbach's α = 0.92). Good concurrent validity was demonstrated by high intraclass correlation coefficients (ICC = 0.97), Bland-Altman plots and moderate to strong correlations to K-BILD, SOBQ and SF-36 (r = - 0.46 to 0.80). High ICC (0.92) and a Bland-Altman plot indicated good test-retest reliability. SGRQ-I was good at discriminating between patients with different stages of disease (Δscore > 18.1, effect sizes > 0.10). Validity was similar across groups of different disease duration.

CONCLUSIONS: SGRQ-I proved to be valid at distinguishing between different disease severities, valid compared to other HRQL instruments, applicable across different disease durations and reliable upon repetition. SGRQ-I is a valid option for measuring HRQL in patients with IPF.

TRIAL REGISTRATION: The study was registered at clinicaltrials.org ( NCT02818712 ) on 15 June 2016.

Original languageEnglish
JournalRespiratory Research
Volume20
Issue number1
Pages (from-to)199
ISSN1465-9921
DOIs
Publication statusPublished - 28 Aug 2019

ID: 59435681